Bioventus Inc Cl A (BVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 22,802 | 41,582 | 43,074 | 31,994 | 25,173 |
| Receivables | 118,082 | 127,393 | 121,925 | 137,305 | 125,541 |
| Inventories | 94,045 | 92,475 | 90,032 | 87,606 | 97,005 |
| Other current assets | 0 | 0 | 26,734 | 28,408 | 0 |
| TOTAL | $249,367 | $275,610 | $298,688 | $308,883 | $265,903 |
| Non-Current Assets | |||||
| PPE Net | 25,722 | 27,012 | 29,425 | 31,938 | 34,532 |
| Investments And Advances | 1,756 | 1,892 | 1,933 | 2,088 | 3,211 |
| Intangibles | 403,193 | 412,191 | 422,271 | 432,014 | 478,130 |
| Other Non-Current Assets | 11,376 | 11,251 | 17,175 | 17,250 | 12,462 |
| TOTAL | $442,047 | $452,346 | $470,804 | $483,290 | $528,335 |
| Total Assets | $691,414 | $727,956 | $769,492 | $792,173 | $794,238 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 37,339 | 27,339 | 38,566 | 38,566 | 35,811 |
| Accounts payable and accrued liabilities | 19,197 | 23,690 | 16,849 | 24,437 | 19,099 |
| Accrued Expenses | 103,283 | 135,879 | 128,697 | 139,978 | 113,605 |
| Other current liabilities | 14,932 | 23,490 | 27,380 | 28,482 | 4,806 |
| TOTAL | $174,751 | $210,398 | $211,492 | $231,463 | $173,321 |
| Non-Current Liabilities | |||||
| Long Term Debt | 308,593 | 308,288 | 345,021 | 344,716 | 355,430 |
| Other Non-Current Liabilities | 22,669 | 23,317 | 26,829 | 35,467 | 48,252 |
| TOTAL | $331,184 | $331,954 | $371,167 | $371,648 | $403,485 |
| Total Liabilities | $505,935 | $542,352 | $582,659 | $603,111 | $576,806 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 82,144 | 81,944 | 81,155 | 80,974 | 79,614 |
| Common Shares | 82 | 82 | 81 | 81 | 80 |
| Retained earnings | -360,298 | -357,661 | -354,922 | -350,098 | -326,106 |
| Other shareholders' equity | 35,273 | 35,091 | 38,540 | 38,110 | 46,481 |
| TOTAL | $185,479 | $185,604 | $186,833 | $189,062 | $217,432 |
| Total Liabilities And Equity | $691,414 | $727,956 | $769,492 | $792,173 | $794,238 |